US Life Science Patents to New Zealand assignees, 2014
The US Patent Office issues new patents every Tuesday. New Zealand assignees generally get one or two healthcare and biotech-related patents a month. Here are the 15 US patents relevant to New Zealand's Life Sciences sector that issued in 2014.
|
US Patent 8,889,636
|
Description: This patent antifungal compounds extracted from Epicoccum nigrum.
|
|
US Patent 8,877,465
|
Title: Production of ultrapure EPA and polar lipids from largely heterotrophic culture
Issued: 4 November 2014 Assignee: Photonz |
Description: This patent covers a method for producing EPA from micro-organisms such as the diatom Nitzschia laevis.
|
|
US Patent 8,835,397
|
Description: This patent covers an improved formulation of ivermectin.
|
|
US Patent 8,821,921
|
Title: Vitamin D3 for the transdermal treatment of pain and inflammation
Issued: 2 September 2014 Assignee: Anzamed International (Dr John Lyftogt) |
Description: This patent covers the use of vitamin D3 in treating neuropathic pain.
|
|
US Patent 8,809,301
|
Title: Surgical hydrogel
Issued: 19 August 2014 Assignee: Robinson Squidgel Ltd (33%), University of Otago (33%), Adelaide Research & Innovation (Australia 33%). |
Description: The patent covers a gel useful in reducing post-surgery sinus scarring, where the actives come from polymers found in squid and crab shell.
|
|
US Patent 8,791,117
|
Title: Cyclic glycyl-2-allyl proline improves cognitive performance in impaired animals
Issued: 29 July 2014 Assignee: Neuren Pharmaceuticals (ASX: NEU) |
Description: This patent covers Neuren's modified tripeptide for the treatment of cognitive impairment.
|
|
US Patent 8,784,795
|
Title: Methods for determining personalized treatment compositions for prostate cancer and breast cancer
Issued: 22 July 2014 Assignee: Caldera Health |
Description: This patent covers the combination of an immune cell activating agent and an antigen display enhancing agent in order to determine the optimal therapy for each patient.
|
|
US Patent 8,758,781
|
Title: Tissue scaffolds derived from forestomach extracellular matrix
Issued: 24 June 2014 Assignee: Aroa Biosurgery |
Description: This patent covers extracellular matrix scaffolds derived from the forestomach of a ruminant, useful in tissue repair.
|
|
US Patent 8,709,448
|
Title: Anti-infective agents and uses thereof
Issued: 29 April 2014 Assignee: Innate Immunotherapeutics (ASX: IIL) |
Description: This patent covers the anti-infective applications of a muramyl dipeptide microparticle, which has immunostimulatory properties.
|
|
US Patent 8,703,699
|
Description: This patent covers a formulation of lactoferrin useful in treating bone-related disorders.
|
|
US Patent 8,679,527
|
Description: This patent covers the antimicrobial actives in honey from Leptospermum scoparium.
|
|
US Patent 8,669,084
|
Description: This patent covers peptide-lipid constructs that spontaneously incorporate into the membranes of cells.
|
|
US Patent 8,637,567
|
Title: Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid
Issued: 28 January 2014 Assignee: Neuren Pharmaceuticals (ASX: NEU) |
Description: This patent covers an analogue to the tripeptide glycyl-L-prolyl-L-glutamic acid useful for treating cognitive impairment.
|
|
US Patent 8,637,473
|
Description: This patent covers water soluble synthetic glycolipids incorporatable into a cell membrane.
|
|
US Patent 8,633,248
|
Title: Parenteral selenomethionine for production of selenium-rich foods
Issued: 21 January 2014 Assignee: AgResearch Ltd |
Description: This patent covers a selenomethionine formulation as a selenium dietary supplement.
|
Copyright © 2016 NDF Research